MedPath

An integrative online self-help program (Deprexis®) versus waitlist control for adults with depressive symptoms

Completed
Conditions
Depressive symptoms
Mental and Behavioural Disorders
Depressive episode
Registration Number
ISRCTN64953693
Lead Sponsor
GAIA AG (Germany)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
200
Inclusion Criteria

1. Aged 18 years or older, either sex
2. Indicate agreement with an electronic consent form

Exclusion Criteria

Does not meet with inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depressive symptom level, measured with the German version of the Beck Depression Inventory (BDI).<br><br>For both the initial treatment group and the control (delayed treatment) group, data were collected at baseline, 9 weeks and 18 weeks. Additionally, participants in the control group completed questionnaires 9 weeks after completing the program (for those in the initial treatment group, this 9-week post-treatment timepoint coincided with the 18-week assessment point mentioned above). Both groups also completed questionnaires 6 months after their respective program usage termination.
Secondary Outcome Measures
NameTimeMethod
1. Work and Social Adjustment Scale (German translation)<br>2. Subjective usefulness of the program, as measured by individually designed items<br><br>For both the initial treatment group and the control (delayed treatment) group, data were collected at baseline, 9 weeks and 18 weeks. Additionally, participants in the control group completed questionnaires 9 weeks after completing the program (for those in the initial treatment group, this 9-week post-treatment timepoint coincided with the 18-week assessment point mentioned above). Both groups also completed questionnaires 6 months after their respective program usage termination.
© Copyright 2025. All Rights Reserved by MedPath